ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Label-free-based quantitative proteomic analysis of the inhibition of cisplatin-resistant ovarian cancer cell proliferation by cucurbitacin B

Yin, Shuanghong; Mai, Zhikai; Liu, Can; Xu, Lipeng*; Xia, Chenglai*南方医科大学
PHYTOMEDICINE2023-3DOI: 10.1016/j.phymed.2023.154669
3被引5阅读
引用收藏
分享

摘要

Background: Ovarian cancer is a serious threat to women's health, and resistance to chemotherapeutic drugs constitutes one of the principal reasons for ovarian cancer recurrence and the low overall survival rate. There-fore, it is of paramount importance to develop additional and more-effective drugs to combat resistance to chemotherapeutic drugs. Cucurbitacin B (CuB) is a natural compound found in food plants such as bitter gourd and pumpkin, and it manifests favorable antitumor effects on a variety of malignant tumors. @@@ Purpose: The present study aimed to determine the mechanism effects of CuB overcomes tumor-drug resistance in ovarian cancer. @@@ Methods: We used CCK-8, Edu, flow cytometric assays and cisplatin-resistant ovarian cancer xenograft mouse model to evaluate the cellular proliferation, cellular apoptosis.and tumor growth. We subsequently applied a pharmacoproteomic approach to analyze the molecular mechanisms by which CuB inhibited the proliferation of cisplatin-resistant ovarian cancer cells. We also employed western blot and molecular docking experiments to verify elements of PI3K/Akt/mTOR pathway expression. @@@ Results: We found that CuB inhibited cellular proliferation and promoted apoptosis in cisplatin-resistant ovarian cancer cell lines. We discerned that CuB inhibited tumor growth of xenograft mouse tumors. We ascertained that treatment of A2780-DDP cells with CuB resulted in the differential expression of 305 proteins, with 202 proteins downregulated and 103 proteins upregulated. Of these proteins, the mTOR protein was significantly down -regulated in the drug-treated group. We also found that CuB inhibited PI3K, Akt, and mTOR and that it activated cGAS expression upstream of PI3K and inhibited ATR expression. Molecular docking experiments revealed that CuB was hydrogen-bonded to mTOR proteins at Gly (2142) and Thr (2207), with a binding force of -10.2 kcal/ mol. @@@ Conclusion: Our study confirmed that cucurbitacin B inhibits the PI3K/Akt/mTOR signaling pathway, targets mTOR, suppresses the proliferation of cisplatin-resistant ovarian cancer cells.And we also found that cucurbitacin B induces DNA damage, activates cGASA and recruits IKB alpha,playing a crucial role in eliciting anti-tumor im-munity. We herein uncovered a new use for CuB in inhibiting tumor-drug resistance, providing a novel approach to overcoming chemotherapeutic drug resistance in ovarian cancer.

学科与关键词

关键词
Ovarian cancerCisplatin resistancePI3K/AKT/mTORcGAS
相关
加载中…
  • Icaritin Inhibits Migration and Invasion of Human Ovarian Cancer Cells via the Akt/mTOR Signaling Pathway
    Gao, Lvfen; Ouyang, Yuan; Li, Ruobin; Zhang, Xian; Gao, Xuesong; Lin, Shaoqiang*; Wang, Xiaoyu*Frontiers in Oncology, 2022, 12: 843489.被引 6
  • mTOR通路在卵巢癌卡铂耐药细胞模型中的作用
    高瑞萍; 唐蔚; 葛秀君; 蒋立艳; 骆婕中国医院药学杂志, 2012, (19): 1536-1539.
  • Anlotinib induces apoptosis and second growth/mitosis phase block in cisplatin-resistant ovarian cancer cells via the aurora kinase A/p53 pathway
    Wang, Hongli*; Wang, YuHuman and Experimental Toxicology, 2023, 42: 09603271231185774.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2023-03
卷期
第 111 卷
页码
154669
DOI
10.1016/j.phymed.2023.154669
语言
GERMAN
成果收录
SCIE

作者

  • Y

    Yin, Shuanghong (第一作者)

    southern med univ

  • M

    Mai, Zhikai

    southern med univ

查看全部 5 位作者收起作者
  • L

    Liu, Can

    southern med univ

  • X

    Xu, Lipeng (通讯)

    new · southern med univ

  • X

    Xia, Chenglai (通讯)

    new · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417